Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Bertagna

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studiesB Guilhaume, X Bertagna, M Thomsen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivationX Bertagna, H Escourolle, J L Pinquier, et al.
The New England Journal of Medicine|April 26, 1990
Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapyJ P Luton, S Cerdas, L Billaud, et al.
European Journal of Endocrinology|February 15, 2001
Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumorsN Boulle, E Baudin, C Gicquel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defectsC Beldjord, F Desclaux-Arramond, M Raffin-Sanson, et al.
Neuropeptides|March 1, 1984
Simultaneous evaluation of the catecholamine pathway and three opioid peptide-producing systems in human pheochromocytomasF Cesselin, L Pique, X Bertagna, et al.
The Journal of Clinical Investigation|March 1, 1996
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndromeY de Keyzer, F Lenne, C Auzan, et al.
Neuroscience Letters|March 15, 1985
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patientsL Pique, S Jegou, X Bertagna, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumorsC Gicquel, M L Raffin-Sanson, V Gaston, et al.
Clinical Endocrinology|May 26, 1999
High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placentaM L Raffin-Sanson, J F Massias, A Ankotche, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studiesB Guilhaume, X Bertagna, M Thomsen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivationX Bertagna, H Escourolle, J L Pinquier, et al.
The New England Journal of Medicine|April 26, 1990
Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapyJ P Luton, S Cerdas, L Billaud, et al.
European Journal of Endocrinology|February 15, 2001
Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumorsN Boulle, E Baudin, C Gicquel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defectsC Beldjord, F Desclaux-Arramond, M Raffin-Sanson, et al.
Neuropeptides|March 1, 1984
Simultaneous evaluation of the catecholamine pathway and three opioid peptide-producing systems in human pheochromocytomasF Cesselin, L Pique, X Bertagna, et al.
The Journal of Clinical Investigation|March 1, 1996
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndromeY de Keyzer, F Lenne, C Auzan, et al.
Neuroscience Letters|March 15, 1985
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patientsL Pique, S Jegou, X Bertagna, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumorsC Gicquel, M L Raffin-Sanson, V Gaston, et al.
Clinical Endocrinology|May 26, 1999
High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placentaM L Raffin-Sanson, J F Massias, A Ankotche, et al.
Pageof 16